Usana Health Sciences (USNA)CHIEF LEGAL OFFICER sold ~$187K

~$187K

Approx. value · 5,732 sh @ $32.54

Traded

Mar 12, 2025

Filed

Mar 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 27, 2025InsiderDirector sold ~$22K of USNA shares in the open market
2. Mar 3, 2025InsiderCEO sold ~$147K of USNA shares in the open market
3. Mar 6, 2025InsiderDirector sold ~$21K of USNA shares in the open market
4. Mar 10, 2025InsiderOfficer sold ~$107K of USNA shares in the open market
5. Mar 11, 2025InsiderDirector sold ~$17K of USNA shares in the open market
6. Mar 12, 2025 · this disclosureInsiderOfficer sold ~$187K of USNA shares in the open market

What came next

1. Mar 12, 2025InsiderOfficer sold ~$153K of USNA shares in the open market
2. May 5, 2025InsiderDirector sold ~$20K of USNA shares in the open market
3. May 9, 2025InsiderCFO sold ~$135K of USNA shares in the open market
4. May 27, 2025InsiderOfficer sold ~$191K of USNA shares in the open market
5. Jun 9, 2025InsiderDirector sold ~$15K of USNA shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Usana Health Sciences

OQRO holds no insider, Congress, fund or contract record for Usana Health Sciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its USNA page.

Other recent filings by Joshua Foukas, CHIEF LEGAL OFFICER

• SEC Form 4 at Usana Health Sciences (USNA)May 8, 2026
• SEC Form 4 at Usana Health Sciences (USNA)Feb 24, 2026

The full history of Joshua Foukas, CHIEF LEGAL OFFICER is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Usana Health Sciences

• SEC Form 4Jun 18, 2026
• SEC Form 4Jun 16, 2026
• SEC Form 4Jun 16, 2026
• SEC Form 4Jun 9, 2026
• SEC Form 4Jun 2, 2026
• SEC Form 4May 29, 2026

Everything OQRO holds on this company is on its USNA page.